Morepen Laboratories Limited — Updates, 27-05-2026: Press Release
27-05-2026 | 08:22 am
27-05-2026 | 08:22 am
Morepen Labs Q4 net profit surged 69% to 20 Cr, with revenue up 22% to 472 Cr. A 10% dividend is proposed. CDMO program began commercial execution (825 Cr/USD 91 Mn mandate). API (+17%), Medical Devices (+31%) drove growth. Capacity expansion to ~800KL underway.
No comments yet. Be the first to comment!
